CrunchBase is hiring! Check out our open positions →
Register | Login or Login

General Information

Websiteremeditex.com
Phone214-506-2662
EmailINNOVATION@REMEDI...
Employees

Funds

Offices

HQ
2101 Cedar Springs
Suite 701
Dallas, TX, 75201
USA

Tags

Remeditex Ventures

Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential. The goal is to help investigators establish the commercial viability of their research making it attractive to traditional investors.

Recent Milestones

Investments

Company Date Round Size Participants
BiO2 Medical 9/12Series C$12M2
Miragen Therapeutics 4/12Series B$20M5
Bellicum Pharmaceuticals 3/12Series B$20M4
Peloton Therapeutics 7/11Series A$18M2

Videos

Sources

  1. BiO2 Medical Raises $12M in Series C Funding (finance.yahoo.com) [edit]
  2. MiRagen Therapeutics Completes $20M Series B Financing (finsmes.com) [edit]
  3. Bellicum Pharmaceuticals Raises $20M in Series B Financing (finsmes.com) [edit]
  4. Peloton Therapeutics Completes $18M Series A Financing (finsmes.com) [edit]
Edit This Page
Last Edited 5/2/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy